Gene · 135152
Papers1,850
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,850
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cytochrome P450 2B6 and UDP-Glucuronosyltransferase Enzyme-Mediated Clearance of Ciprofol (HSK3486) in Humans: The Role of Hepatic and Extrahepatic Metabolism. | Drug Metab Dispos | 2024 | 38071562 | PubTator, text mining | PubMed |
| Medicinal Chemistry and NMR Driven Discovery of Novel UDP-glucuronosyltransferase 1A Inhibitors That Overcome Therapeutic Resistance in Cells. | J Mol Biol | 2024 | 38043731 | PubTator, text mining | PubMed |
| Ciprofol is primarily glucuronidated by UGT1A9 and predicted not to cause drug-drug interactions with typical substrates of CYP1A2, CYP2B6, and CYP2C19. | Chem Biol Interact | 2024 | 37993078 | PubTator, text mining | PubMed |
| Predicting routes of phase I and II metabolism based on quantum mechanics and machine learning. | Xenobiotica | 2024 | 37966132 | PubTator, text mining | PubMed |
| Molecular regulators of exercise-mediated insulin sensitivity in non-obese individuals. | J Cell Mol Med | 2024 | 37938877 | PubTator, text mining | PubMed |
| Sexual dimorphism in bladder cancer: a review of etiology, biology, diagnosis, and outcomes. | Front Pharmacol | 2023 | 38283839 | PubTator, text mining | PubMed |
| Clinical and genetic risk factors associated with neonatal severe hyperbilirubinemia: a case-control study based on the China Neonatal Genomes Project. | Front Genet | 2023 | 38274110 | PubTator, text mining | PubMed |
| Biotransformation of Δ1-Progesterone Using Selected Entomopathogenic Filamentous Fungi and Prediction of Its Products' Bioactivity. | Int J Mol Sci | 2023 | 38203679 | PubTator, text mining | PubMed |
| Anti-Cancer Properties of Resveratrol: A Focus on Its Impact on Mitochondrial Functions. | Antioxidants (Basel) | 2023 | 38136176 | PubTator, text mining | PubMed |
| Application of artificial intelligence approaches to predict the metabolism of xenobiotic molecules by human gut microbiome. | Front Microbiol | 2023 | 38116528 | PubTator, text mining | PubMed |
| Role of Genetic Polymorphisms in the Development of Complications in Patients with Implanted Left Ventricular Assist Devices: HeartWare, HeartMate II, and HeartMate 3. | J Clin Med | 2023 | 38068287 | PubTator, text mining | PubMed |
| Gut liver brain axis in diseases: the implications for therapeutic interventions. | Signal Transduct Target Ther | 2023 | 38057297 | PubTator, text mining | PubMed |
| Molecular mechanisms of resveratrol as chemo and radiosensitizer in cancer. | Front Pharmacol | 2023 | 38026933 | PubTator, text mining | PubMed |
| Phytochemicals Target Multiple Metabolic Pathways in Cancer. | Antioxidants (Basel) | 2023 | 38001865 | PubTator, text mining | PubMed |
| Quantitative analysis of the UDP-glucuronosyltransferase transcriptome in human tissues. | Pharmacol Res Perspect | 2023 | 37983911 | PubTator, text mining | PubMed |
| Harnessing Ferroptosis to Overcome Drug Resistance in Colorectal Cancer: Promising Therapeutic Approaches. | Cancers (Basel) | 2023 | 37958383 | PubTator, text mining | PubMed |
| CYP1A2 expression rather than genotype is associated with olanzapine concentration in psychiatric patients. | Sci Rep | 2023 | 37898643 | PubTator, text mining | PubMed |
| Molecular and Cellular Insights: A Focus on Glycans and the HNK1 Epitope in Autism Spectrum Disorder. | Int J Mol Sci | 2023 | 37894820 | PubTator, text mining | PubMed |
| Statins and Cardiomyocyte Metabolism, Friend or Foe? | J Cardiovasc Dev Dis | 2023 | 37887864 | PubTator, text mining | PubMed |
| Disruption of sugar nucleotide clearance is a therapeutic vulnerability of cancer cells. | Nature | 2023 | 37880368 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/135152/papers?page=6